Cytokinetics Inc. buy Morgan Stanley
Start price
13.02.25
/
50%
€41.00
Target price
13.02.26
€64.45
Performance (%)
31.71%
Price
12.12.25
€54.00
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Cytokinetics Inc. has seen massive gains of 31.71%. This prediction currently runs until 13.02.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -4.425% | -4.425% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Morgan_Stanley for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $67.00 price target on the stock, down previously from $70.00.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Morgan_Stanley for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€30.20
04.08.23
04.08.23
€54.39
04.08.24
04.08.24
67.22%
05.08.24
05.08.24
